About Us
Asia Pacific Oncology Drug Development Consortium

Asia Pacific Oncology Drug Development Consortium (APODDC) was established in 2021 to foster education and collaboration between key stakeholders of oncology drug development within the Asia Pacific region, thereby improving treatment access to patients.

Our objectives

Develop interests and insights in oncology drug development in the Asia Pacific region

Improve clinical trials infrastructure through continuous training and information sharing across committed clinical trials sites in this region

Extend educational reach of academic centres and initiate collaborative projects pertaining to oncology drug development and accessibility within this region

Further understand opportunities and challenges of oncology drug development and accessibility within this region, given its diversity in healthcare access and socio-economic status

Copyright © 2022 Asia Pacific Oncology Drug Development Consortium (APODDC) | Website Designed By Elves Lab | Privacy